Modulating MyoD1 dosage activates alternate cell fate beyond myogenic differentiation [RNA-seq]
RNA-seq (gene expression) · mouse · 47 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 47 samples: 16 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE309939_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1364018 and SRA study SRP644556. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 47 samples.
How we read this: 16 replicated groups read from 47 sample titles; they account for 47 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9285028 C2C12 cells, iMyoD1, no differentiation, dox treatment, RNA-seq biol rep 1 C2C12 cells, iMyoD1, no…
- GSM9285029 C2C12 cells, iMyoD1, no differentiation, dox treatment, RNA-seq biol rep 2 C2C12 cells, iMyoD1, no…
- GSM9285030 C2C12 cells, iMyoD1, no differentiation, dox treatment, RNA-seq biol rep 3 C2C12 cells, iMyoD1, no…
- GSM9285031 C2C12 cells, iMyoD1, no differentiation, untreated, RNA-seq biol rep 1 C2C12 cells, iMyoD1, no…
- GSM9285032 C2C12 cells, iMyoD1, no differentiation, untreated, RNA-seq biol rep 2 C2C12 cells, iMyoD1, no…
- GSM9285033 C2C12 cells, iMyoD1, no differentiation, untreated, RNA-seq biol rep 3 C2C12 cells, iMyoD1, no…
- GSM9285034 C2C12 cells, iMyoD1, 24 h serum starvation, dox treatment, RNA-seq biol rep 1 C2C12 cells, iMyoD1, 24…
- GSM9285035 C2C12 cells, iMyoD1, 24 h serum starvation, dox treatment, RNA-seq biol rep 2 C2C12 cells, iMyoD1, 24…
- GSM9285036 C2C12 cells, iMyoD1, 24 h serum starvation, dox treatment, RNA-seq biol rep 3 C2C12 cells, iMyoD1, 24…
- GSM9285037 C2C12 cells, iMyoD1, 24 h serum starvation, untreated, RNA-seq biol rep 1 C2C12 cells, iMyoD1, 24…
- GSM9285038 C2C12 cells, iMyoD1, 24 h serum starvation, untreated, RNA-seq biol rep 2 C2C12 cells, iMyoD1, 24…
- GSM9285039 C2C12 cells, iMyoD1, 24 h serum starvation, untreated, RNA-seq biol rep 3 C2C12 cells, iMyoD1, 24…
- GSM9722054 C2C12 cells, iCdh23, 48 h serum starvation, untreated, RNA-seq biol rep 1 C2C12 cells, iCdh23, 48…
- GSM9722055 C2C12 cells, iCdh23, 48 h serum starvation, untreated, RNA-seq biol rep 2 C2C12 cells, iCdh23, 48…
- GSM9722056 C2C12 cells, iCdh23, 48 h serum starvation, untreated, RNA-seq biol rep 3 C2C12 cells, iCdh23, 48…
- GSM9722057 C2C12 cells, iCdh23, 48 h serum starvation, dox treatment, RNA-seq biol rep 1 C2C12 cells, iCdh23, 48…
- GSM9722058 C2C12 cells, iCdh23, 48 h serum starvation, dox treatment, RNA-seq biol rep 2 C2C12 cells, iCdh23, 48…
- GSM9722059 C2C12 cells, iCdh23, 48 h serum starvation, dox treatment, RNA-seq biol rep 3 C2C12 cells, iCdh23, 48…
- GSM9722060 C2C12 cells, iMcam, 48 h serum starvation, untreated, RNA-seq biol rep 1 C2C12 cells, iMcam, 48 …
- GSM9722061 C2C12 cells, iMcam, 48 h serum starvation, untreated, RNA-seq biol rep 2 C2C12 cells, iMcam, 48 …
- GSM9722062 C2C12 cells, iMcam, 48 h serum starvation, untreated, RNA-seq biol rep 3 C2C12 cells, iMcam, 48 …
- GSM9722063 C2C12 cells, iMcam, 48 h serum starvation, dox treatment, RNA-seq biol rep 1 C2C12 cells, iMcam, 48 …
- GSM9722064 C2C12 cells, iMcam, 48 h serum starvation, dox treatment, RNA-seq biol rep 2 C2C12 cells, iMcam, 48 …
- GSM9722065 C2C12 cells, iMcam, 48 h serum starvation, dox treatment, RNA-seq biol rep 3 C2C12 cells, iMcam, 48 …
- GSM9722066 C2C12 cells, iMyoD1, 120 h serum starvation, >40 um myotube-enriched fraction, untreated, RNA-seq biol rep 1 C2C12 cells, iMyoD1, 12…
- GSM9722067 C2C12 cells, iMyoD1, 120 h serum starvation, >40 um myotube-enriched fraction, untreated, RNA-seq biol rep 2 C2C12 cells, iMyoD1, 12…
- GSM9722068 C2C12 cells, iMyoD1, 120 h serum starvation, >40 um myotube-enriched fraction, untreated, RNA-seq biol rep 3 C2C12 cells, iMyoD1, 12…
- GSM9722069 C2C12 cells, iMyoD1, 120 h serum starvation, >40 um myotube-enriched fraction, dox treatment, RNA-seq biol rep 1 C2C12 cells, iMyoD1, 12…
- GSM9722070 C2C12 cells, iMyoD1, 120 h serum starvation, >40 um myotube-enriched fraction, dox treatment, RNA-seq biol rep 2 C2C12 cells, iMyoD1, 12…
- GSM9722071 C2C12 cells, iMyoD1, 120 h serum starvation, >40 um myotube-enriched fraction, dox treatment, RNA-seq biol rep 3 C2C12 cells, iMyoD1, 12…
- GSM9722072 C2C12 cells, iMyoD1, 120 h serum starvation, <40 um myoblast-enriched fraction, untreated, RNA-seq biol rep 1 C2C12 cells, iMyoD1, 12…
- GSM9722073 C2C12 cells, iMyoD1, 120 h serum starvation, <40 um myoblast-enriched fraction, untreated, RNA-seq biol rep 2 C2C12 cells, iMyoD1, 12…
- GSM9722074 C2C12 cells, iMyoD1, 120 h serum starvation, <40 um myoblast-enriched fraction, untreated, RNA-seq biol rep 3 C2C12 cells, iMyoD1, 12…
- GSM9722075 C2C12 cells, iMyoD1, 120 h serum starvation, <40 um myoblast-enriched fraction, dox treatment, RNA-seq biol rep 2 C2C12 cells, iMyoD1, 12…
- GSM9722076 C2C12 cells, iMyoD1, 120 h serum starvation, <40 um myoblast-enriched fraction, dox treatment, RNA-seq biol rep 3 C2C12 cells, iMyoD1, 12…
- GSM9722077 C2C12 cells, iMyoD1, 48 h serum starvation, untreated, RNA-seq biol rep 1 C2C12 cells, iMyoD1, 48…
- GSM9722078 C2C12 cells, iMyoD1, 48 h serum starvation, untreated, RNA-seq biol rep 2 C2C12 cells, iMyoD1, 48…
- GSM9722079 C2C12 cells, iMyoD1, 48 h serum starvation, untreated, RNA-seq biol rep 3 C2C12 cells, iMyoD1, 48…
- GSM9722080 C2C12 cells, iMyoD1, 48 h serum starvation, dox treatment, RNA-seq biol rep 1 C2C12 cells, iMyoD1, 48…
- GSM9722081 C2C12 cells, iMyoD1, 48 h serum starvation, dox treatment, RNA-seq biol rep 2 C2C12 cells, iMyoD1, 48…
+ 7 more — browse all 47 samples with per-sample file links →
- GSE309864 Modulating MyoD1 dosage activates alternate cell fate beyond myogenic differentiation [ATAC-seq] 16 samples shares myod1, modulating, activates, alternate, myogenic, dosage, beyond
- GSE222745 Enhanced activities of OCT4 and SOX2 facilitates epigenetic reprogramming by modulating cell cycle [scRNA-Seq] 422 samples shares modulating, rna-seq
- GSE298786 Type I IFN impedes early bacterial control in TB-resistant and -susceptible mice and activates neutrophils to restrict lung macrophage-T cell interactions [RNA-seq] 70 samples shares activates, rna-seq
- GSE313112 Inhibition of METTL3 by STC-15 induces RNA misprocessing that results in dsRNA formation and activates innate immunity [RNA-Seq MC38] 69 samples shares activates, rna-seq
- GSE307328 KRAS inhibition activates an actionable CD24 "Don't eat me" signal in pancreatic cancer [RNA-seq] 45 samples shares activates, rna-seq
- GSE312675 Pressure Overload-Induced Ventricular Crosstalk Activates Regenerative Mechanisms in the Contralateral Ventricle in Neonatal Mice [RNA-Seq] 22 samples shares activates, rna-seq
- GSE294133 CLU alleviates Alzheimer’s disease-relevant processes by modulating astrocyte reactivity and microglia-dependent synaptic density [RNA-Seq] 19 samples shares modulating, rna-seq
- GSE255807 Transcriptional and epigenetic rewiring by the NUP98::KDM5A fusion oncoprotein directly activates CDK12 (RNA-Seq) 16 samples shares activates, rna-seq
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.